Compositions And Methods Comprising A Defined Microbiome And Methods Of Use Thereof

Abstract

The invention features the use of a defined microbial consortia for the replacement of a gut microbiome associated with disease. In particular, the invention provides for the treatment of hyperammonemia, Clostridium difficile colitis, hepatic encephalopathy associated with cirrhosis, and inflammatory bowel disease.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Aug 28, 2018
  • Application: Apr 4, 2016
    US US 201615090609 A
  • Priority: Apr 4, 2016
    US US 201615090609 A
  • Priority: Jul 14, 2015
    US US 201562192406 P
  • Priority: Oct 3, 2014
    US US 2014/0059166 W
  • Priority: Apr 3, 2014
    US US 201461974686 P
  • Priority: Oct 3, 2013
    US US 201361886268 P

Download Citation


Sign in to the Lens

Feedback